Regeneus to fast track human stem cell osteoarthritis therapies in Japan - Proactive Investors Australia

Regeneus to fast track human stem cell osteoarthritis therapies in JapanProactive Investors AustraliaChief executive officer Professor Graham Vesey added the Japanese law provided the company with a well-defined pathway to fast-track the clinical trial and potential approval of its new human off-the-shelf cell therapy to treat osteoarthritis and other read more

http://blog.zandcell.com/regeneus-to-fast-track-human-stem-cell-osteoarthritis-therapies-in-japan-proactive-investors-australia/?utm_source=rss&utm_medium=rss&utm_campaign=regeneus-to-fast-track-human-stem-cell-osteoarthritis-therapies-in-japan-proactive-investors-australia